News
UB-led study describes the cause of aortic stiffness in Marfan syndrome
Aortic aneurysm and fibrotic response Marfan syndrome Article reference:
ONCE and IDIBELL collaborating on a project on hereditary blindness
ONCE collaborates in the project led by Ana Mendez Zunzunegui from the Cellular and molecular basis of sensory disorders research group at Bellvitge Biomedical Reseach Institute (IDIBELL) and professor at the University of Barcelona, which aims to identify new therapeutic targets against hereditary blindness. Hereditary retinal dystrophies are disorders with great clinical and genetic heterogeneity […]
The XIV International Course of Gynecologic Surgery Robotic surgery broadcasts live in 3D
Robotic surgery is able to reduce the average hospital stay of highly complex procedures to 2.2 days The robotic surgical system with three-dimensional view provides greater accuracy and security both in laparoscopic surgery and oncology. The University Hospital of Bellvitge, with support from the Institute of Biomedical Research of Bellvitge (IDIBELL), has since 2009 of […]
A blood could replace lung cancer biopsies
Liquid biopsy Different mutations, different prognosis
IDIBELL Neuroscientists in Brain Awareness Week
Neuroscience at schools ‘Pessics’ with Brain Awareness Week
Ignacio Gonzalez Bravo awards a Consolidator Grant from the European Research Council
The head of the Infections and Cancer Lab at ICO-IDIBELL, Ignacio Gonzalez Bravo has received a Consolidator Grant from the European Research Council (ERC) to develop his CODOVIREVOL project: “Evolution of viral codon usage preferences: manipulation of translation accuracy and evasion of immune response “. The grant entails financing of 2 million euros for the […]
Francisco Miguel Torres, new responsible of quality and scientific indicators management at IDIBELL
This year has been incorporated Francisco Miguel Torres in the IDIBELL as a new quality manager and responsible of scientific indicators of the institution. Francisco Miguel Torres graduated in Biology at the University of Barcelona and did a doctorate at the Vall d’Hebron Institute of Oncology (VHIO). He worked as a postdoctoral researcher at the […]